Dec 20, 2022, 02:00 by ASAM Weekly Editors

Dec 13, 2022, 19:00 by ASAM Weekly Editors

Dec 13, 2022, 14:31 by Molly McGrath

Dec 12, 2022, 10:36 by ASAM Weekly Editors

Dec 8, 2022, 10:28 by Molly McGrath

Nov 29, 2022, 09:24 by ASAM Weekly Editors

Dr. Nora Volkow, director of the National Institute on Drug Abuse, recently advocated for broadening access to methadone treatment for OUD (STAT News). While some politicians or trade groups may frame this as radical, such leading-expert opinion is based on scientific evidence and an appreciation for a rapidly evolving addiction crisis.

Nov 23, 2022, 09:15 by Bob Davis

On November 22nd, the Oregon Society of Addiction Medicine (ORSAM) wrote a comment letter to the Oregon Department of Consumer and Business Services expressing support for proposed changes to the Mental Health Parity Rules. The rule changes build upon landmark parity legislation that was signed into law in 2021.

Nov 22, 2022, 08:00 by ASAM Weekly Editors

Nov 18, 2022, 15:45 by Molly McGrath

Nov 17, 2022, 09:21 by Bob Davis

With both chambers of Congress advancing the Medical Marijuana and Cannabidiol Research Expansion Act, ASAM encourages President Biden to sign the bipartisan legislation into law.

Nov 15, 2022, 15:35 by Molly McGrath

On November 15th, ASAM submitted comments to the U.S. Senators Patty Murray and Richard Burr, suggesting improvements to the Senate HELP Committee's mental health and substance use disorder legislative package.

Nov 15, 2022, 10:58 by Bob Davis

Nov 10, 2022, 12:56 by Molly McGrath

On November 10th, ASAM and the Legal Action Center (LAC) co-led a letter to the U.S. Senate Finance Committee in response to the committee’s Enhancing the Mental Health Workforce discussion draft.

Nov 8, 2022, 18:00 by Bob Davis

Nov 7, 2022, 17:02 by Bob Davis

In response to significant member interest, ASAM developed a report detailing the availability of buprenorphine at pharmacies. The report is divided into two versions: a shorter, topline brief and a longer form report with information about methodology, statistical analysis, and data visualization charts.

Nov 2, 2022, 13:47 by Molly McGrath

On November 1st, the California Society of Addiction Medicine (CSAM) sent written comments to the California Department of Insurance in response to their prenotice public discussion for the implementation of SB 855.

Nov 2, 2022, 08:00 by Bob Davis

Nov 1, 2022, 11:00 by Bob Davis

Oct 27, 2022, 09:21 by Bob Davis

On October 25th, the Arkansas Society of Addiction Medicine (ARSAM) sent a letter to the Arkansas Medicaid Drug Review Committee (DRC) urging for the committee to remove utilization management restrictions on long-acting injectable medications.

Oct 25, 2022, 15:01 by Bob Davis